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Skeletal muscles in animals with metabolic syndrome exhibit reduced oxidative capacity. We 
investigated the effects of running exercise on fiber characteristics, oxidative capacity, and 
mRNA levels in the soleus muscles of rats with metabolic syndrome (SHR/NDmcr-cp (cp/cp); 
CP). We divided 5-week-old CP rats into non-exercise (CP) and exercise (CP-Ex) groups. 
Wistar-Kyoto rats (WKY) were used as the control group. CP-Ex rats were permitted 
voluntary exercise on running wheels for 10 weeks. Triglyceride levels were higher and 
adiponectin levels lower in the CP and CP-Ex groups than in the WKY group. However, 
triglyceride levels were lower and adiponectin levels higher in the CP-Ex group than in the 
CP group. The soleus muscles in CP-Ex rats contained only high-oxidative type I fibers, 
whereas those in WKY and CP rats contained type I, IIA, and IIC fibers. Muscle succinate 
dehydrogenase (SDH) activity was higher in the CP-Ex group than in the CP group; there was 
no difference in SDH activity between the WKY and CP-Ex groups. Muscle proliferator-
activated receptor γ coactivator-1α (PGC-1α) mRNA levels were higher in the CP-Ex group 
than in the CP group; there was no difference in PGC-1α mRNA levels between the WKY and 
CP-Ex groups. In CP-Ex rats, longer running distance was associated with increased muscle 
SDH activity and PGC-1α mRNA levels. We concluded that running exercise restored 
decreased muscle oxidative capacity and PGC-1α mRNA levels and improved 
hypertriglyceridemia in rats with metabolic syndrome. 
 








CP  SHR/NDmcr-cp (cp/cp) 
CPT-I  Carnitine palmitoyltransferase-I 
GLUT4 Glucose transporter 4 
HPRT  Hypoxanthine phosphoribosyltransferase 
MCAD Medium-chain acyl-CoA dehydrogenase 
PGC-1α PPARγ coactivator-1α 
PPAR  Peroxisome proliferator-activated receptor 
SCD-1  Stearoyl-CoA desaturase-1 
SDH  Succinate dehydrogenase 
SHR  Spontaneously hypertensive rat 
TFAM  Mitochondrial transcriptional factor A 






Metabolic syndrome is closely related to physical inactivity and consumption of a high-
fat and high-calorie diet. Increased energy intake is the major cause of excessive body weight 
and leads to increased blood pressure and glucose levels. Metabolic syndrome ultimately will 
develop into a lifestyle-related disease, e.g., cardiovascular disease and type 2 diabetes [1–3]. 
The skeletal muscles are the major site of insulin action and glucose metabolism; reduced 
muscle oxidative capacity impairs oxidative metabolism and increases the risk for the 
development of metabolic syndrome, lifestyle-related diseases, and associated complications 
[4]. The skeletal muscles in patients with type 2 diabetes contain a lower percentage of high-
oxidative fibers than those in healthy individuals [5–8]. Furthermore, we observed that the 
soleus muscles in rats with type 2 diabetes contain a lower percentage of high-oxidative fibers 
than those in non-diabetic rats [9–12]. 
The skeletal muscle characteristics are regulated mainly by peroxisome proliferator-
activated receptors (PPARs), e.g., PPARα, PPARδ/β, and PPARγ, and PPARγ coactivator-1α 
(PGC-1α) [13–15]. We had previously reported that the soleus muscles in rats with type 2 
diabetes contain lower levels of PGC-1α mRNA than those in non-diabetic rats [16, 17]. 
Therefore, we concluded that low PGC-1α mRNA levels in the soleus muscles in rats with 
type 2 diabetes are associated with a low percentage of high-oxidative fibers. 
In the present study, we hypothesized that running exercise would increase oxidative 
capacity and PGC-1α mRNA levels in the skeletal muscles of patients and animals with 
metabolic syndrome and lifestyle-related diseases. We examined the slow soleus muscles in 
rats with metabolic syndrome that were permitted voluntary exercise on a running wheel; 
specifically, we focused on fiber characteristics (including type distribution, cross-sectional 




metabolism. We expected marked improvement in the oxidative capacity of the soleus 
muscles in rats with metabolic syndrome following running exercise. The soleus muscles in 
normal rats exhibit increased oxidative capacity and function at relatively low intensity for a 
long duration. The soleus muscles are required to function against gravity, e.g., to maintain 
posture and to walk [18]; this indicates that these muscles function most effectively during 
oxidative metabolism. We used the SHR/NDmcr-cp (cp/cp) (CP) rat as an animal model for 
metabolic syndrome. CP rats have a nonsense mutation in the leptin receptor and develop 
obesity, high blood pressure and glucose levels, hyperinsulinemia, and dyslipidemia during 
adult stages [19, 20]. 
 
Materials and methods 
All experimental procedures and animal care were performed in accordance with the 
Guide for the Care and Use of Laboratory Animals published by the US National Institute of 
Health and the Japanese Physiological Society. This study was approved by the Institutional 
Animal Care and Experiment Committee of Kyoto University (Kyoto, Japan). 
 
Experimental animals and treatment 
Five-week-old male CP rats were divided into 2 groups: non-exercise (CP; n = 6) and 
exercise (CP-Ex; n = 6) groups. Age-matched male Wistar-Kyoto rats were used as the control 
group (WKY; n = 6). All rats were obtained from Japan SLC Inc. (Hamamatsu, Japan). The 
WKY and CP rats were housed in individual cages of uniform size (30 × 40 × 20 cm). The 
CP-Ex rats were allowed voluntary exercise on a running wheel for 10 weeks. The rats had 
24-h free access to the running wheels. The running wheel apparatus included a standard 




was attached to the cage [21]. The number of revolutions per 24-h period was recorded using 
a computer. All groups were provided the standard diet (3.60 kcal/g, 23.6% protein, 5.3% fat, 
and 54.4% carbohydrates; Oriental Yeast Co. Ltd., Tokyo, Japan) and water ad libitum. The 
caloric intake of each rat was measured daily. The room was maintained at 22 ± 2°C in a 
controlled 12-h light/dark cycle (light period from 0800 to 2000) with 45–55% relative 
humidity. The body weights and systolic and diastolic blood pressure levels of the rats were 
measured at 5, 7, 9, 11, 13, and 15 weeks of age. Systolic and diastolic blood pressure levels 
were determined automatically in conscious rats by using the indirect tail-cuff method with a 
sphygmomanometer (BP-98A, Softron Inc., Tokyo, Japan). 
 
Blood glucose analyses 
Glucose levels were measured at 5, 7, 9, 11, 13, and 15 weeks of age after a 15-h fasting 
period. Blood samples were obtained from the tails of fully conscious rats and analyzed with a 
glucose meter (GT-1650; Arkray Inc., Kyoto, Japan). The same glucose meter was used to 
measure non-fasting glucose levels at 15 weeks of age. 
 
Serum biochemical analyses 
The CP-Ex rats (15 weeks of age) were placed in cages without running wheels 1 day 
before their blood was sampled. After fasting glucose levels were measured, the rats were 
administered an intraperitoneal injection of pentobarbital sodium (5 mg/100 g body weight), 
and blood samples were obtained from the abdominal aorta. The serum levels of triglyceride, 
total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) 
cholesterol, and free fatty acids were measured using routine laboratory methods. The serum 




linked immunosorbent assay kits for rats (Shibayagi Co. Ltd., Shibukawa, Japan). 
 
Muscle biochemical analyses 
After blood sampling, the soleus muscle was removed from each leg and measured (wet 
muscle weight). For biochemical and histochemical analyses, the right soleus muscle was 
divided into distal and proximal components. The distal component was thawed, minced, and 
homogenized in 5 volumes of ice-cold 0.3 M phosphate buffer (pH 7.4) with a glass 
homogenizer for the analysis of succinate dehydrogenase (SDH) activity, an indicator of 
mitochondrial oxidative capacity [22]. The homogenate was diluted further in the same buffer, 
and 0.04 mL of the homogenate was added to 0.1 mL of sodium succinate solution in a 
cuvette. After 2 min, 0.1 mL of sodium cyanide (NaCN) was added to the cuvette. The 
reaction was initiated by adding 2.8 mL of cytochrome c-salt solution. The cuvette was 
transferred to the spectrophotometer; the reduction in cytochrome c was evident because of 
increase in extinction at 550 nm. Then, sodium hydrosulfite was added and the extinction was 
determined. This reading represented the complete reduction of cytochrome c. Sodium 
succinate was added at a concentration of 17 mM. The final concentrations of the components 
in the reaction mixture were sodium succinate, 17 mM; NaCN, 1 mM; aluminum chloride 
(AlCl3), 0.4 mM; calcium chloride (CaCl2), 0.4 mM; cytochrome c, 0.017 mM; and phosphate 
buffer, 0.04 M. The reduction of cytochrome c in this reaction mixture was analyzed 
spectrophotometrically by observing the increase in extinction at 550 nm. The SDH activity 
was calculated on the basis of ferricytochrome c concentration. Protein concentration was 
determined by the method of Lowry et al. [23]. 
 




The proximal component of the right muscle was pinned to a corkboard and rapidly 
frozen in isopentane that had been cooled with a mixture of dry ice and acetone. The muscle 
was mounted on a specimen chuck with Tissue-Tek OCT compound (Sakura Finetechnical Co. 
Ltd., Tokyo, Japan). Serial transverse sections were cut at a thickness of 10 μm by using a 
cryostat at -20°C. The fiber types were classified on the basis of ATPase activity [24, 25]. The 
sections were brought to room temperature, air dried for 30 min, and preincubated in acidic 
(pH 4.5) or alkaline (pH 10.4) solution for the subsequent assessment of ATPase activity. The 
muscle fibers in each section were classified as type I (positive results for ATPase with 
preincubation at pH 4.5 and negative results for ATPase with preincubation at pH 10.4), type 
IIA (negative results for ATPase with preincubation at pH 4.5 and positive results for ATPase 
with preincubation at pH 10.4), and type IIC (positive results for ATPase with preincubation 
at pH 4.5 and 10.4). A computer-assisted image processing system (Neuroimaging System 
Inc., Kyoto, Japan) was used to digitize a single common segment selected from each section 
as gray level images. The cross-sectional area was measured by tracing the outline of each 
fiber in the section. The fiber-type distribution and cross-sectional area were determined for 
approximately 500 fibers in the central region of the muscle section. 
The sections were stained for 10 min to evaluate SDH staining intensity [24, 25]. The 
SDH staining intensity was quantified in the 500 fibers by using the computer-assisted image 
processing system. The sectional images were digitized as gray scale images. Each pixel was 
quantified as one of 256 gray levels; gray level 0 was equivalent to 100% light transmission, 
and gray level 255 was equivalent to 0% light transmission. The mean optical density (OD) of 
all pixels (which were converted to gray level values) within a fiber was determined using a 
calibration photographic tablet containing 21 gradient-density range steps and corresponding 





Muscle mRNA analyses 
Total RNA was extracted from the left muscle by using TRIzol Reagent (Invitrogen, 
Carlsbad, CA) and then treated with deoxyribonuclease I (Invitrogen). The PrimeScript RT 
reagent kit (Takara Bio Inc., Otsu, Japan) was used to synthesize the first strand of cDNA 
from 1.0 µg of total RNA. We analyzed gene expression by using real-time polymerase chain 
reaction with a LightCycler system DX400 (Roche Diagnostics, Mannheim, Germany) and 
SYBR Premix Ex Taq II (Takara Bio Inc.). The mRNA levels of PPARα, PPARδ/α, PGC-1α, 
glucose transporter 4 (GLUT4), stearoyl-CoA desaturase-1 (SCD-1), carnitine 
palmitoyltransferase-I (CPT-I), medium-chain acyl-CoA dehydrogenase (MCAD), and 
mitochondrial transcriptional factor A (TFAM) were normalized to the mRNA levels of 
hypoxanthine phosphoribosyltransferase (HPRT). The following primer sets were used:  
PPARα forward, 5′-CACCCTCTCTCCAGCTTCCA-3′  
PPARα reverse, 5′-GCCTTGTCCCCACATATTCG-3′  
PPARδ/β forward, 5′-AACGAGATCAGCGTGCATGTG-3′  
PPARδ/β reverse, 5′-TGAGGAAGAGGCTGCTGAAGTT-3′  
PGC-1α forward, 5′-CGATGACCCTCCTCACACCA-3′  
PGC-1α reverse, 5′-TTGGCTTGAGCATGTTGCG-3′  
GLUT4 forward, 5′-CAACTGGACCTGTAACTTCATCGT-3′  
GLUT4 reverse, 5′-ACGGCAAATAGAAGGAAGACGTA-3′  
SCD-1 forward, 5′-TGGGAAAGTGAAGCGAGCAACCG-3′  
SCD-1 reverse, 5′-AGAGGGGCACCTTCTTCATCTTCT C-3′  
CPT-I forward, 5′-TCCTACCAGATGGAGAGGATGT-3′  




MCAD forward, 5′-TGCTGGAAATGATCAACAGAAG-3′  
MCAD reverse, 5′-CATCACCCTTCTTCTCTGCTTT-3′  
TFAM forward, 5′-GAAACGCCTAAAGAAGAAAGCA-3′  
TFAM reverse, 5′-CTGACTCATCCTTAGCCTCC TG-3′  
HPRT forward, 5′-CTCATGGACTGATTATGGACAGGAC-3′  
HPRT reverse, 5′-GCAGGTCAGCAAAGAACTTATAGCC-3′ 
 
Statistical analyses 
Standard procedures were used to calculate the mean, standard deviation, and correlation 
coefficient from individual values. All measured values were presented as mean and standard 
deviation. One-way analysis of variance was used to determine significant mean differences 
among the 3 groups. Mean values determined to be significantly different were subjected to 
additional comparison analysis by using Scheffé’s post hoc tests. A probability level of 0.05 
was considered significant. 
 
Results 
Voluntary running distance 
Rats in the CP-Ex group ran the greatest distance at 7 weeks of age (Fig. 1). During the 
10-week exercise period, the average running distance was 2.3 km/day. 
 
Fig. 1. Voluntary running distances in the CP-Ex group. Data are 
presented as mean and standard deviation (n = 6). aP < 0.05, compared 





Body weight and caloric intake 
Body weight at 9–15 weeks of age was higher in the CP and CP-Ex groups than in the 
age-matched WKY group (Fig. 2a). The caloric intake at 5–15 weeks of age was higher in the 
CP and CP-Ex groups than in the age-matched WKY group (Fig. 2b). Furthermore, the caloric 
intake at 9–15 weeks of age was higher in the CP-Ex group than in the age-matched CP group. 
 
 
Fig. 2. Body weights (a), caloric intakes (b), and systolic (c) 
and diastolic (d) blood pressure levels in the WKY, CP, and 
CP-Ex groups. Data are presented as mean and standard 
deviation (n = 6). cP < 0.05, compared to age-matched WKY 
group; dP < 0.05, compared to age-matched WKY and CP 
groups. 
 
Blood pressure levels 
The systolic blood pressure levels at 9–15 weeks of age were higher in the CP and CP-Ex 
groups than in the age-matched WKY group (Fig. 2c). The diastolic blood pressure levels at 
11–15 weeks of age were higher in the CP and CP-Ex groups than in the age-matched WKY 
group (Fig. 2d). 
 
Blood glucose levels 
Fasting glucose levels at 5–7 weeks of age were higher in the CP and CP-Ex groups than 
in the age-matched WKY group (Fig. 3a). Non-fasting glucose levels at 15 weeks of age were 





Fig. 3. Fasting (a) and non-fasting (b) blood glucose levels 
in the WKY, CP, and CP-Ex groups. Data are presented as 
mean and standard deviation (n = 6). cP < 0.05, compared to 
age-matched WKY group. 
 
Serum biochemical parameters 
The levels of triglyceride (Fig. 4a), insulin (Fig. 4f), and leptin (Fig. 4g) were higher in 
the CP and CP-Ex groups than in the WKY group. Total cholesterol levels were higher in the 
CP group than in the WKY group (Fig. 4b). HDL-cholesterol (Fig. 4c) and adiponectin (Fig. 
4h) difference in the levels of LDL-cholesterol (Fig. 4d) or free fatty acids (Fig. 4e) among 
the WKY, CP, and CP-Ex groups. Triglyceride levels were lower (Fig. 4a) and adiponectin 
levels higher (Fig. 4h) in the CP-Ex group than in the CP group. 
 
Fig. 4. The levels of triglyceride (a), total 
cholesterol (b), HDL-cholesterol (c), LDL-
cholesterol (d), free fatty acids (e), insulin (f), 
leptin (g), and adiponectin (h) in the WKY, CP, 
and CP-Ex groups. Data are presented as mean 
and standard deviation (n = 6). HDL, high-
density lipoprotein; LDL, low-density lipoprotein. cP < 0.05, compared to WKY group; dP < 0.05, compared to 
WKY and CP groups. 
 
Muscle weight and SDH activity 
The muscle weight (Fig. 5a) and relative muscle weight per body weight (Fig. 5b) were 
lower in the CP group than in the WKY and CP-Ex groups. Muscle SDH activity was lower in 




Fig. 5. Soleus muscle weights (a), relative 
muscle weights per body weight (b), 
muscle SDH activities (c), fiber type 
percentages (d), fiber cross-sectional areas 
(e), and fiber SDH staining intensities (f) 
in the WKY, CP, and CP-Ex groups. Data 
are presented as mean and standard 
deviation (n = 6). BW, body weight; SDH, 
succinate dehydrogenase; CSA, cross-sectional area; OD, optical density. cP < 0.05, compared to WKY group; 
dP < 0.05, compared to WKY and CP groups; eP < 0.05, compared to WKY and CP-Ex groups. 
 
Muscle fiber profiles 
The muscles in WKY and CP rats contained 3 types of fibers (Fig. 6). In contrast, the 
muscles in CP-Ex rats contained only type I fibers. The percentage of type I fibers was lower 
and the percentages of type IIA and IIC fibers were higher in the CP group than in the WKY 
group (Fig. 5d). The cross-sectional area of type I fibers was smaller in the CP group than in 
the WKY and CP-Ex groups (Fig. 5e). The cross-sectional areas of type IIA and IIC fibers 
were smaller in the CP group than in the WKY group. The SDH staining intensity of type I 
fibers was higher in the CP-Ex group than in the WKY and CP groups (Fig. 5f). 
 
 
Fig. 6. Serial transverse sections of the soleus muscles from 
WKY (a–c), CP (d–f), and CP-Ex (g–i) rats stained for ATPase 
activity after preincubation at pH 10.4 (a, d, and g) and pH 4.5 
(b, e, and h) and for SDH activity (c, f, and i). 1, type I; 2, type 






Muscle mRNA levels 
PPARα mRNA levels were higher (Fig. 7a) and PPARδ/β and PGC-1α mRNA levels 
lower (Fig. 7b, c) in the CP group than in the WKY and CP-Ex groups. SCD-1 mRNA levels 
were higher in the CP and CP-Ex groups than in the WKY group (Fig. 7e). There was no 
difference in the mRNA levels of GLUT4 (Fig. 7d), CPT-I (Fig. 7f), MCAD (Fig. 7g), or 
TFAM (Fig. 7h) among the WKY, CP, and CP-Ex groups. 
Fig. 7. The mRNA levels of PPARα (a), PPARδ/β 
(b), PGC-1α (c), GLUT4 (d), SCD-1 (e), CPT-I (f), 
MCAD (g), and TFAM (h) in the soleus muscles of 
the WKY, CP, and CP-Ex groups. Data are 
presented as mean and standard deviation (n = 6). 
PPAR, peroxisome proliferator-activated receptor; 
PGC-1α, PPARγ coactivator-1α; GLUT4, glucose transporter 4; SCD-1,stearoyl-CoA desaturase-1; CPT-I, 
carnitine palmitoyltransferase-I; MCAD, medium-chain acyl-CoA dehydrogenase; TFAM, mitochondrial 
transcriptional factor A. cP < 0.05, compared to WKY group; eP < 0.05, compared to WKY and CP-Ex groups. 
 
Relationships between running distance and muscle SDH activity and PGC-1α mRNA levels 
The running distance of individual rats in the CP-Ex group correlated positively with 
muscle SDH activity (Fig. 8a) and PGC-1α mRNA levels (Fig. 8b). 
Fig. 8. Relationships between running distance and 
SDH activity (r = 0.90, n = 6, P < 0.01; a) and PGC-1α 
mRNA levels (r = 0.90, n = 6, P < 0.01; b) in the soleus 








Obesity, defined as an increase in adipose tissue mass, is associated with various 
metabolic diseases. CP rats, which are used as an animal model for metabolic syndrome, were 
established from an inbred subline of obese, spontaneously hypertensive SHR/N-cp (cp/cp) 
rats [19, 20]. CP rats are characterized by risk factors for metabolic syndrome, including high 
blood pressure and glucose levels, hyperinsulinemia, and dyslipidemia. The 15-week-old CP 
rats used in the present study showed signs of metabolic syndrome, including increased body 
weight (Fig. 2a); high systolic and diastolic blood pressure levels (Fig. 2c, d); and increased 
levels of glucose (Fig. 3b), triglyceride (Fig. 4a), and insulin (Fig. 4f). 
Limited data are available on the skeletal muscle characteristics of patients and animals 
with metabolic syndrome under various conditions, such as excessive caloric intake and/or 
decreased muscle activity. In the present study, we compared the fiber characteristics and 
mRNA levels in the soleus muscles of CP rats that were permitted running exercise to those 
of non-obese WKY and obese CP rats. 
At 9–15 weeks of age, the CP-Ex group showed greater caloric intake than the CP group 
(Fig. 2b). However, the 2 groups showed similar body weight at all ages (Fig. 2a). CP-Ex rats 
may have maintained sufficient energy expenditure and oxidative metabolism to complete 
their daily exercise. Rats are highly active and exercise spontaneously on running wheels at 
their own pace that allows them to run greater distances than what is normally observed 
during forced treadmill exercise regimens. Voluntary running primarily induces aerobic 
adaptation in the skeletal muscles [26–28], and fiber hypertrophy can develop in the soleus 
muscles of rats [26, 29]. In the present study, the average running distance per day in the CP-
Ex group was relatively low (2.3 km/day), compared to that (about 16 km/day) noted in 




normal rats with the same running wheel apparatus [30]. However, in the present study, the 
skeletal muscles (Fig. 5c) and fibers (Fig. 5f) showed higher oxidative enzyme activity in 
response to exercise. This indicated that the CP-Ex group expended sufficient energy to 
improve the oxidative metabolism in skeletal muscles. 
Insulin and leptin stimulate the sympathetic system [31, 32], and this contributes to 
increased blood pressure. In the present study, the CP and CP-Ex groups exhibited high 
systolic (Fig. 2c) and diastolic (Fig. 2d) blood pressure levels and increased levels of insulin 
(Fig. 4f) and leptin (Fig. 4g), compared to those exhibited by the WKY group. In contrast, 
running exercise restored adiponectin levels, which had decreased in the rats with metabolic 
syndrome (Fig. 4h). Low adiponectin levels are associated with subsequent development of 
cardiovascular disease and type 2 diabetes [33]. In the present study, we showed that a 10-
week of running exercise did not induce any changes in the levels of glucose (Fig. 3a) or 
insulin (Fig. 4f) of the CP-Ex group. However, running exercise did increase adiponectin 
levels (Fig. 4h). Therefore, we speculate that insulin sensitivity would improve further with 
continued running exercise. 
The CP group exhibited lower soleus muscle weight than the WKY group (Fig. 5a, b). 
The soleus muscle is an antigravity and postural muscle that is continually active and 
therefore, more susceptible to decreased physical activity. In contrast, the soleus muscle 
weight (Fig. 5a, b) and cross-sectional area of type I fiber (Fig. 5e) in the CP-Ex group were 
greater than those in the CP group and similar to those in the WKY group. Therefore, we 
concluded that lower muscle weight in the CP group was associated with lower physical 
activity and loading levels. 
The soleus muscles in CP rats contained type I, IIA, and IIC fibers, whereas those in CP-




running exercise induce a shift of fibers from types IIA and IIC to high-oxidative type I. In the 
present study, a complete shift of all fibers to type I in the soleus muscles of the CP-Ex group 
was observed. Fiber type shifts occur under a variety of conditions, such as growth, aging, 
disease, and increased or decreased muscle activity [34]. To our knowledge, no previous 
studies have reported the shift of all fibers to a single type―with the exception of our finding 
that the soleus muscles in adult rats with type 2 diabetes contain only type I fibers that have 
lower oxidative enzyme activity than type IIA and IIC fibers [9–12]. However, the mechanism 
underlying the complete shift of fibers to a single type in the soleus muscles of CP-Ex rats 
remains unclear. 
Previous studies [35, 36] revealed that hypertriglyceridemia and insulin resistance are 
associated with increased SCD-1 activity. The present study showed that SCD-1 mRNA levels 
were 8.6- and 5.8-fold greater in the CP and CP-Ex groups, respectively, than in the WKY 
group (Fig. 7e). We concluded that hypertriglyceridemia (Fig. 4a) and hyperinsulinemia (Fig. 
4f) observed in the CP and CP-Ex groups were associated with increased SCD-1 mRNA 
levels. 
PGC-1α mRNA levels in the soleus muscles were higher in the CP-Ex group than in the 
CP group (Fig. 7c). In addition, there was no difference in PGC-1α mRNA levels between the 
WKY and CP-Ex groups (Fig. 7c). It is suggested that running exercise restored decreased 
PGC-1α mRNA levels and improved the oxidative capacity of skeletal muscles in rats with 
metabolic syndrome. In fact, the oxidative capacity of the soleus muscles (Fig. 5c) and fibers 
(Fig. 5f) was higher in the CP-Ex group than in the CP group. 
Voluntary running distance correlated positively with muscle SDH activity (Fig. 8a) and 
PGC-1α mRNA levels (Fig. 8b). The rats with metabolic syndrome that ran longer distances 




enhances muscle oxidative capacity in rats with metabolic syndrome. The oxidative capacity 




The development and progression of metabolic syndrome depend on genetic background 
but are also highly influenced by daily lifestyle. CP rats possess genetic factors that easily 
induce metabolic syndrome, however, running exercise prevents decrease in muscle oxidative 
capacity and PGC-1α mRNA levels. Furthermore, longer running distances correlate with 
higher muscle oxidative enzyme activity and PGC-1α mRNA levels. We concluded that 
running exercise restores decreased muscle oxidative capacity and PGC-1α mRNA levels and 
improves hypertriglyceridemia in rats with metabolic syndrome. 
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